First reported case of secondary mixed phenotype acute leukemia after multiple myeloma

In recent years the outcome of patients with multiple myeloma (MM) has significantly improved, due to new drugs. However, some agents, i.e. the alkylating drug melphalan, can be associated with an increased incidence of secondary malignancies. Myelodysplastic syndromes and acute myeloid leukemia are...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Blood Res
Autors principals: Bacchiarri, Francesca, Sammartano, Vincenzo, Santoni, Adele, Raspadori, Donatella, Zappone, Elisabetta, Defina, Marzia, Ciofini, Sara, Sicuranza, Anna, Bocchia, Monica, Gozzetti, Alessandro
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2021
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8010609/
https://ncbi.nlm.nih.gov/pubmed/33796400
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars